Feb 10, 2026, 09:45 AM by

Feb 10, 2026, 01:01 AM by User Not Found

Bio-IT World | After a turbulent few years for biotechnology, investors and entrepreneurs are recalibrating. That shift was the main topic of conversation in the most recent Trends from the Trenches episode, with John Keilty, venture partner at Third Rock Ventures, and host Eleanor Howe, founder and CEO of Diamond Age Data Science.

Feb 9, 2026, 07:42 AM by

Feb 9, 2026, 07:42 AM by

New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.

Feb 6, 2026, 07:26 AM by

Feb 6, 2026, 01:01 AM by User Not Found

Bio-IT World | For decades, the role of statistical programmers in drug development was clearly defined. They were responsible for producing validated tables, listings, and figures from clinical trial data, most often using statistical analysis systems, within structured workflows for regulatory submissions. That model is now under pressure.

Feb 4, 2026, 07:51 AM by

Cirena has announced its public launch following successful delivery of high-quality long RNA to leading academic and pharmaceutical research teams across the U.S., Europe, and Japan.

Feb 4, 2026, 07:51 AM by

Feb 3, 2026, 16:00 PM by User Not Found

Bio-IT World | Yesterday, PacBio announced the completion of the sale of short-read DNA sequencing technology to Illumina. PacBio received $48.1 million in net cash proceeds from the transaction. The sale closed on January 30, 2026.

Feb 3, 2026, 01:01 AM by User Not Found

Bio-IT World | It has been known for some time now that for people with irregular sleep patterns, including shift workers and frequent travelers across time zones, disruptions to the body’s circadian rhythm can be deadly. The dangers have notably included heightened risk of aggressive breast cancer.

Jan 30, 2026, 08:41 AM by

Jan 29, 2026, 01:00 AM by User Not Found

Bio-IT World | Earlier this month at the J.P. Morgan Healthcare Conference, Eli Lilly Chairman and CEO David Ricks spoke at a fireside chat and presented what the company has planned for 2026, which also marks its 150th anniversary. This year is expected to be a productive one in terms of clinical trial activity, wider availability of medicines, and expansion into new therapeutic areas.

Jan 28, 2026, 08:44 AM by

The project aims at Quantitative Systems Pharmacology modeling of a T-cell engager to identify first-in-human dose and predict optimal step-up dosing regimen

Jan 28, 2026, 08:44 AM by

Jan 28, 2026, 01:01 AM by User Not Found

Bio-IT World | Parabilis Medicines will continue the clinical development of FOG-001 (zolucatetide), the company’s lead investigational Helicon peptide; Alveus Therapeutics will advance into Phase 2 clinical development of ALV-100, the company’s lead program; Soley Therapeutics plans to advance its proprietary cell stress sensing platform; and more.

Jan 27, 2026, 10:44 AM by

Jan 27, 2026, 10:44 AM by

Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform.

Jan 27, 2026, 10:44 AM by

Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations

Jan 27, 2026, 10:44 AM by

• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America • Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development

Jan 27, 2026, 10:44 AM by

Ceryx has strengthened its Board of Directors with the appointment of Mark Strong.